The present invention relates to a mesoglycan drug delivery dosage form in which 1) 100 parts by weight of mesoglycan, 2) 10-50 parts by weight of cholic acid and 3) 10-100 parts by weight of hydrophilic and hydrophobic surfactants are adsorbed and coupled, wherein the hydrophilic surfactant is a nonionic surfactant having an HLB value of 12 or more and the hydrophobic surfactant is a nonionic surfactant having an HLB value of 8 or less.La présente invention concerne une forme posologique dadministration de médicament de mésoglycane, dans laquelle 1) 100 parties en poids de mésoglycane, 2) 10-50 parties en poids dacide cholique et 3) 10-100 parties en poids de tensioactifs hydrophiles et hydrophobes sont adsorbés et couplés, le tensioactif hydrophile étant un tensioactif non-ionique ayant une valeur HLB de 12 ou plus et le tensioactif hydrophobe étant un tensioactif non-ionique ayant une valeur HLB de 8 ou moins.본 발명은 1) 100 중량부의 메소글리칸, 2) 10~50 중량부의 콜린산 및 3) 10~100 중량부의 친수성 및 소수성 계면활성제를 흡착 결합시킨 메소글리칸 약물 전달 제형에 있어서, 상기 친수성 계면활성제는 HLB 밸류가 12 이상인 비이온성 계면활성제이고, 상기 소수성 계면활성제는 HLB 밸류가 8 이하인 비이온성 계면활성제임을 특징으로 하는 메소글리칸 약물전달 제형에 관한 것이다.
